FDA Inspection 618945 — Novartis Pharma Schweizerhalle Ag

Novartis Pharma Schweizerhalle Ag — FEI 3002865753

The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on September 10, 2009 in Pratteln. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pratteln (Switzerland)